Site map
All sections and documents in this edition.
- Sikalias Greek Formulary | 310 compounding monographs
- 310 compounding monographs
- Aqueous Calamine Cream · CGR-BP-001
- Aqueous Cream · CGR-BP-002
- Benzyl Benzoate Application · CGR-BP-003
- Buffered Cream · CGR-BP-004
- Calamine and Coal Tar Ointment · CGR-BP-005
- Calamine Lotion · CGR-BP-006
- Calamine Ointment · CGR-BP-007
- Calcium Hydroxide Solution · CGR-BP-008
- Cetomacrogol Emulsifying Ointment · CGR-BP-009
- Cetomacrogol Emulsifying Wax · CGR-BP-010
- Cetrimide Cream 0.5% w/w · CGR-BP-011
- Compound Zinc Paste · CGR-BP-012
- Dithranol Ointment · CGR-BP-013
- Emulsifying Ointment · CGR-BP-014
- Emulsifying Wax · CGR-BP-015
- Glycerol Suppositories · CGR-BP-016
- Hydrous Ointment · CGR-BP-017
- Magnesium Sulfate Paste · CGR-BP-018
- Methyl Salicylate Ointment · CGR-BP-019
- Simple Ointment · CGR-BP-020
- Sodium Bicarbonate Ear Drops · CGR-BP-021
- Syrup · CGR-BP-022
- Wool Alcohols Ointment · CGR-BP-023
- Zinc and Castor Oil Ointment · CGR-BP-024
- Zinc and Coal Tar Paste · CGR-BP-025
- Zinc and Ichthammol Cream · CGR-BP-026
- Zinc and Salicylic Acid Paste · CGR-BP-027
- Zinc Cream · CGR-BP-028
- Zinc Ointment · CGR-BP-029
- Alcoholic Iodine Solution · CGR-BP-030
- Aqueous Iodine Oral Solution · CGR-BP-031
- Aluminium Acetate Ear Drops · CGR-BP-032
- Flexible Collodion · CGR-BP-033
- Benzoin Inhalation · CGR-BP-034
- Compound Benzoin Tincture · CGR-BP-035
- Peppermint Spirit · CGR-BP-036
- Diluent A FTM — lactose · CGR-BE-001
- Diluent B FTM — mannitol · CGR-BE-002
- Preserved water FTM · CGR-BE-003
- Buffered cetomacrogol cream FTM · CGR-BE-004
- Carbomer 980 gel FTM · CGR-BE-005
- Hydrated sorbitan sesquioleate petrolatum FTM · CGR-BE-006
- MCC/carmellose dispersion FTM · CGR-BE-007
- Permethrin cream 5% w/w FTM · CGR-BE-008
- Hydrocortisone acetate cream 1% FTM · CGR-BE-009
- Urea lipophilic cream 10% FTM · CGR-BE-010
- Urea hydrophilic cream 10% FTM · CGR-BE-011
- Metronidazole gel 1% FTM · CGR-BE-012
- Minoxidil cutaneous solution 2% w/w FTM · CGR-BE-013
- Spironolactone capsules 25 mg FTM · CGR-BE-014
- Omeprazole oral suspension 2 mg/g FTM · CGR-BE-015
- Paracetamol capsules 250–500 mg FTM · CGR-BE-016
- Macrocrystalline nitrofurantoin oral suspension 6 mg/mL FTM · CGR-BE-017
- Trimethoprim oral suspension 10 mg/mL FTM · CGR-BE-018
- Riboflavin capsules 400 mg FTM · CGR-BE-019
- Miconazole base oral gel 2% FTM · CGR-BE-020
- Iodine alcoholic solution 1% Ph. Fr. · CGR-FR-001
- Cosmetic cerate Ph. Fr. · CGR-FR-002
- Galen cerate Ph. Fr. · CGR-FR-003
- Modified Galen cerate Ph. Fr. · CGR-FR-004
- Glycerinated cerate Ph. Fr. · CGR-FR-005
- Collodion Ph. Fr. · CGR-FR-006
- Therapeutic placebo tablets Ph. Fr. · CGR-FR-007
- Oleo-calcareous cream Ph. Fr. · CGR-FR-008
- Carmine capsules 200–500 mg Ph. Fr. · CGR-FR-009
- Nadolol capsules 1–50 mg Ph. Fr. · CGR-FR-010
- Starch glycerolate Ph. Fr. · CGR-FR-011
- Zinc oxide starch glycerolate Ph. Fr. · CGR-FR-012
- Therapeutic placebo capsules Ph. Fr. · CGR-FR-013
- Spironolactone capsules 0.5–25 mg Ph. Fr. · CGR-FR-014
- Sodium chloride capsules 50 mg–1 g Ph. Fr. · CGR-FR-015
- Amiodarone hydrochloride capsules 5–200 mg Ph. Fr. · CGR-FR-016
- Sodium bicarbonate capsules Ph. Fr. · CGR-FR-017
- Oleo-calcareous liniment Ph. Fr. · CGR-FR-018
- Salicylic acid ointment 1–50% Ph. Fr. · CGR-FR-019
- Zinc oxide paste, Lassar, Ph. Fr. · CGR-FR-020
- Acacia oral vehicle (potion gommeuse) Ph. Fr. · CGR-FR-021
- Copper and zinc ointment, camphor-free Dalibour · CGR-FR-022
- Camphor ointment 10% or 20% Ph. Fr. · CGR-FR-023
- Zinc oxide ointment 10% Ph. Fr. · CGR-FR-024
- Aqueous zinc paste, Darier, Ph. Fr. · CGR-FR-025
- Therapeutic placebo syrup Ph. Fr. · CGR-FR-026
- Simple syrup Ph. Fr. · CGR-FR-027
- Glycerol oral solution 0.644 g/mL Ph. Fr. · CGR-FR-028
- Beeler cream base AEMPS · CGR-ES-001
- Preserved water without propylene glycol AEMPS · CGR-ES-002
- AEMPS preserved syrup — nominal 84% w/v · CGR-ES-003
- Sodium carmellose oral gel 1% AEMPS · CGR-ES-004
- Metronidazole gel 1% AEMPS · CGR-ES-005
- Hydrochlorothiazide oral suspension 2 mg/mL AEMPS · CGR-ES-006
- Captopril oral solution 1 mg/mL AEMPS · CGR-ES-007
- Furosemide oral solution 2 mg/mL AEMPS · CGR-ES-008
- Enalapril maleate oral solution 1 mg/mL AEMPS · CGR-ES-009
- Amlodipine 0.5 mg/mL oral solution · CGR-ES-010
- Hydrocortisone oral suspension 1 mg/mL AEMPS · CGR-ES-011
- Gabapentin oral solution 50 mg/mL AEMPS · CGR-ES-012
- Sodium citrate/citric acid oral solution AEMPS · CGR-ES-013
- Artificial saliva AEMPS · CGR-ES-014
- Urea cream 15% AEMPS · CGR-ES-015
- Minoxidil cutaneous solution 2% w/w AEMPS · CGR-ES-016
- Cetrimide Emulsifying Ointment · CGR-BP-037
- Chloroxylenol Solution · CGR-BP-038
- Coal Tar Solution · CGR-BP-039
- Strong Coal Tar Solution · CGR-BP-040
- Compound Benzoic Acid Ointment · CGR-BP-041
- Compound Aluminium Paste · CGR-BP-042
- Compound Glucose Sodium Chloride and Sodium Citrate Oral Solution · CGR-BP-043
- Soap Spirit · CGR-BP-044
- Concentrated Anise Water · CGR-BP-045
- Concentrated Camphor Water · CGR-BP-046
- Concentrated Cinnamon Water · CGR-BP-047
- Benzoic Acid Solution · CGR-BP-048
- Buffered Cetomacrogol Emulsion FTM · CGR-BE-021
- Anionic Hydrophilic Cream FTM · CGR-BE-022
- Econazole Nitrate Cream 1% w/w · CGR-BE-023
- Miconazole Nitrate Cream 2% w/w · CGR-BE-024
- Miconazole Nitrate Emulsion 2% w/w · CGR-BE-025
- Crotamiton Cream 10% w/w · CGR-BE-026
- Crotamiton Emulsion 10% w/w · CGR-BE-027
- Clindamycin Phosphate Solution 1.5% w/w as Clindamycin · CGR-BE-028
- Erythromycin Gel 2% or 4% w/w · CGR-BE-029
- Erythromycin Hydroalcoholic Solution 4% w/w · CGR-BE-030
- Acetazolamide Capsules 250 mg · CGR-BE-031
- Hydrocortisone Capsules 10 or 20 mg · CGR-BE-032
- Cetirizine Dihydrochloride Capsules 10 mg · CGR-BE-033
- Diosmin Capsules 500 mg · CGR-BE-034
- Loperamide Hydrochloride Capsules 2 mg · CGR-BE-035
- Aciclovir Oral Suspension 400 mg/5 mL · CGR-BE-036
- Metronidazole Benzoate Suspension 200 mg/5 mL as Metronidazole · CGR-BE-037
- Ibuprofen Gel 5% w/w · CGR-BE-038
- Aluminium Chloride Hexahydrate Solution 15% w/w · CGR-BE-039
- Hydrogen Peroxide Ear Solution 3% w/w · CGR-BE-040
- Hydroxybenzoate Concentrate EX025 · CGR-ES-017
- Preserved Water EX001 · CGR-ES-018
- Nonionic O/W Emulsion 1 EX010 · CGR-ES-019
- Nonionic O/W Emulsion 2 EX011 · CGR-ES-020
- Neutral Carbomer 940 Gel EX020 · CGR-ES-021
- Simple Syrup 84% w/v EX022 · CGR-ES-022
- Aluminium Acetate Solution AEMPS · CGR-ES-023
- Acetic Acid Ear Drops AEMPS · CGR-ES-024
- Lidocaine Hydrochloride Anaesthetic Gel 1% w/w · CGR-ES-025
- Hydrocortisone Cream 0.5% w/w AEMPS · CGR-ES-026
- Viscous Lidocaine Hydrochloride 0.5% w/w · CGR-ES-027
- Weak Lugol Solution AEMPS 2025 · CGR-ES-028
- Clonidine Hydrochloride Oral Solution 20 micrograms/mL · CGR-ES-029
- Isoniazid Oral Solution 50 mg/mL · CGR-ES-030
- Ethambutol Hydrochloride Oral Solution 50 mg/mL · CGR-ES-031
- Pyridoxine Hydrochloride Oral Solution 25 mg/mL · CGR-ES-032
- Dexamethasone Oral Solution 1 mg/mL · CGR-ES-033
- Hydralazine Hydrochloride Oral Solution 10 mg/mL · CGR-ES-034
- Folic Acid Oral Solution 1 mg/mL · CGR-ES-035
- Thiamine Hydrochloride Oral Solution 100 mg/mL · CGR-ES-036
- Riboflavin Oral Solution 25 mg/mL · CGR-ES-037
- Aqueous Chlorhexidine Digluconate Solution 0.1% AEMPS · CGR-ES-038
- Disodium Eosin Aqueous Solution 2% w/v · CGR-ES-039
- Zinc Sulfate Heptahydrate Solution 0.1% w/v · CGR-ES-040
- Absorptive Cream JP · CGR-JP-001
- Hydrophilic Cream JP · CGR-JP-002
- Macrogol Ointment JP · CGR-JP-003
- Hydrophilic Petrolatum JP · CGR-JP-004
- Acetazolamide 25 mg/mL oral suspension · CGR-US-001
- Allopurinol 20 mg/mL oral suspension · CGR-US-002
- Amiodarone 5 mg/mL oral suspension · CGR-US-003
- Atenolol 2 mg/mL oral solution · CGR-US-004
- Bethanechol 5 mg/mL oral suspension · CGR-US-005
- Carvedilol 0.5 mg/mL oral suspension · CGR-US-006
- Celecoxib 10 mg/mL oral suspension · CGR-US-007
- Cinacalcet 5 mg/mL oral suspension · CGR-US-008
- Lamotrigine 1 mg/mL oral suspension · CGR-US-009
- Nifedipine 4 mg/mL oral suspension · CGR-US-010
- Quinidine sulfate 10 mg/mL oral suspension · CGR-US-011
- Rifabutin 20 mg/mL oral suspension · CGR-US-012
- Tinidazole 66.7 mg/mL oral suspension · CGR-US-013
- Verapamil 50 mg/mL oral suspension · CGR-US-014
- Baclofen 10 mg/mL oral suspension · CGR-CA-001
- Clobazam 1 mg/mL oral suspension · CGR-CA-002
- Diazoxide 10 mg/mL oral suspension · CGR-CA-003
- Domperidone 1 mg/mL oral suspension · CGR-CA-004
- Glycopyrrolate 0.5 mg/mL oral suspension · CGR-CA-005
- Lisinopril 1 mg/mL oral suspension · CGR-CA-006
- Prednisone 5 mg/mL oral suspension · CGR-CA-007
- Melatonin 1 mg/mL oral suspension · CGR-NZ-001
- Carvedilol 1 mg/mL oral suspension · CGR-NZ-002
- Sotalol hydrochloride 5 mg/mL oral suspension · CGR-NZ-003
- Terbinafine 25 mg/mL oral suspension · CGR-NZ-004
- Dipyridamole 10 mg/mL oral suspension · CGR-NZ-005
- Flecainide acetate 20 mg/mL oral suspension · CGR-NZ-006
- Phenobarbital sodium 10 mg/mL oral solution · CGR-NZ-007
- Paraben concentrate 6% + 3% w/w · CGR-BR-001
- Citric acid 25–50% w/v auxiliary solution · CGR-BR-002
- Imidazolidinyl urea 50% w/v preservative solution · CGR-BR-003
- Triethanolamine 50% w/v auxiliary solution · CGR-BR-004
- High-viscosity hydroxyethylcellulose gel · CGR-BR-005
- Fluid hydroxyethylcellulose gel · CGR-BR-006
- Nonionic lotion base I — FNFB · CGR-BR-007
- Vanishing cream — FNFB · CGR-BR-008
- Anionic cream I — FNFB · CGR-BR-009
- Sodium chloride 25% w/v thickening intermediate · CGR-BR-010
- Sodium fluoride 0.05% w/v mouth rinse · CGR-BR-011
- Chlorhexidine digluconate 0.1% w/v mouth rinse · CGR-BR-012
- Aluminium hydroxide 6% w/v suspension · CGR-BR-013
- Aluminium hydroxide 6% and magnesium hydroxide 4% w/v suspension · CGR-BR-014
- Lidocaine hydrochloride 2% w/v oromucosal topical solution · CGR-BR-015
- Simple syrup 85% w/v — FNFB · CGR-BR-016
- Amoxicillin 125 / 250 / 500 mg capsules from bulk API · CGR-FR-029
- Aprepitant 20 mg/mL from 80 mg capsules · CGR-FR-030
- Clarithromycin 250 / 500 mg capsules · CGR-FR-031
- Flucytosine 50 mg/mL oral suspension · CGR-FR-032
- Sertraline 25 / 50 mg capsules · CGR-FR-033
- Quetiapine 50 / 100 / 150 mg immediate-release capsules · CGR-FR-034
- Firm hydrophilic cream 1 EX003 · CGR-ES-041
- Firm hydrophilic cream 2 EX004 · CGR-ES-042
- Anionic O/W emulsion EX007 · CGR-ES-043
- Fluid nonionic O/W emulsion EX009 · CGR-ES-044
- Nonionic O/W emulsion 3 EX012 · CGR-ES-045
- W/O emulsion EX005 Cold cream · CGR-ES-046
- Water-in-silicone emulsion EX006 · CGR-ES-047
- Fluid anionic O/W emulsion EX008 · CGR-ES-048
- Capsule diluent 1 EX013 · CGR-ES-049
- Capsule diluent 2 EX014 · CGR-ES-050
- Oral adhesive gel EX015 · CGR-ES-051
- Carmellose sodium gel 2% EX016 · CGR-ES-052
- Methylcellulose gel 4% EX017 · CGR-ES-053
- Fluid methylcellulose gel 1% EX018 · CGR-ES-054
- Hydroalcoholic methylcellulose gel EX019 · CGR-ES-055
- Neutral hydroalcoholic carbomer gel EX021 · CGR-ES-056
- Bentonite magma 5% EX023 · CGR-ES-057
- Hydroalcoholic vehicle 1 EX026 · CGR-ES-058
- Hydroalcoholic vehicle 2 EX027 · CGR-ES-059
- Camphorated oil 10% PO001 · CGR-ES-060
- Salicylic oil 5% with ethanol PO003 · CGR-ES-061
- Salicylic oil 5% without ethanol PO004 · CGR-ES-062
- Thymol water 0.1% PO008 · CGR-ES-063
- Menthol spirit 5% w/v PO012 · CGR-ES-064
- Calamine lotion PO014 · CGR-ES-065
- Aqueous zinc paste PO017 · CGR-ES-066
- Lassar paste without salicylic acid PO018 · CGR-ES-067
- Mentholated zinc oxide powder PO020 · CGR-ES-068
- Menthol petrolatum 1% PO031 · CGR-ES-069
- Hydrocortisone acetate 0.5%, phenol 0.5%, menthol 0.2% and zinc oxide 2% cream · CGR-ES-070
- Salicylic acid 5% and triamcinolone acetonide 0.1% cream · CGR-ES-071
- Silver nitrate cutaneous solution 2% w/w · CGR-ES-072
- Tannic acid alcoholic solution 10% w/v · CGR-ES-073
- Menthol 10% and methyl salicylate 15% analgesic ointment · CGR-ES-074
- Copper sulfate pentahydrate cutaneous solution 0.1% w/v · CGR-ES-075
- Rosemary essential oil alcoholic solution 5% v/v · CGR-ES-076
- Peru balsam ointment 6% w/w · CGR-ES-077
- Camphor spirit 10% w/v · CGR-ES-078
- Menthol 1% and thymol 1% rubefacient in rosemary spirit · CGR-ES-079
- White Ointment JP · CGR-JP-005
- Zinc Oxide Ointment JP 20% w/w · CGR-JP-006
- Ethanol for Disinfection JP · CGR-JP-007
- Iodine Tincture JP 6% with potassium iodide 4% · CGR-JP-008
- Zinc Oxide Starch Powder JP 50% w/w · CGR-JP-009
- Sulfur and Camphor Lotion JP · CGR-JP-010
- Salicylic Acid Spirit JP 3% w/v · CGR-JP-011
- Salicylated Alum Powder JP 3% w/w · CGR-JP-012
- Hydrocortisone Acetate 0.5% and Diphenhydramine Base 0.5% Ointment JP · CGR-JP-013
- Acrinol Hydrate 1% and Zinc Oxide Ointment JP · CGR-JP-014
- Zinc Oxide Oil JP 50% w/w — Olive Oil JP variant · CGR-JP-015
- Acrinol Hydrate 1% and Zinc Oxide Oil JP · CGR-JP-016
- Patent Blue V coloured alcohol 60% v/v · CGR-FR-035
- Silver nitrate sticks 633 mg/g · CGR-FR-036
- Colloidal silver ointment · CGR-FR-037
- Hawthorn tincture · CGR-FR-038
- Witch-hazel tincture · CGR-FR-039
- Hawthorn fluid extract · CGR-FR-040
- Witch-hazel fluid extract · CGR-FR-041
- Passionflower fluid extract · CGR-FR-042
- Salicylic acid 6% and triamcinolone acetonide 0.1% gel · CGR-ES-080
- Salicylic acid and lactic acid collodion · CGR-ES-081
- Erythromycin 2% cream · CGR-ES-082
- Methadone hydrochloride 10 mg/mL (1% w/v) aqueous oral solution · CGR-ES-083
- Morphine hydrochloride 10 mg/mL (1% w/v) oral solution with simple syrup · CGR-ES-084
- Lidocaine HCl 1% compound buccal suspension · CGR-ES-085
- Phenobarbital 10 mg/mL expressed as base, from sodium salt — oral solution · CGR-ES-086
- Chloral hydrate 5% w/v enema (50 mg/mL) · CGR-ES-087
- Chloral hydrate 10% w/v oral syrup with preservative (100 mg/mL) · CGR-ES-088
- Gomenol 2% w/w cutaneous oil solution · CGR-ES-089
- Tannic acid cutaneous solution in ethanol–glycerol, 5 g/50 mL/50 mL formula · CGR-ES-090
- Boric acid 3% w/v aqueous cutaneous solution · CGR-ES-091
- Saturated boric acid otic solution in ethanol 70% — 5 g/100 mL charge · CGR-ES-092
- Iodine 2% w/v alcoholic solution with potassium iodide 2.5% w/v · CGR-ES-093
- Glycerol–wheat starch cutaneous gel, 90/10/10 g formula · CGR-ES-094
- Potassium permanganate 0.01% w/v (1 in 10,000) cutaneous solution · CGR-ES-095
- Racemic camphor 10% w/w ointment with white beeswax 8% w/w · CGR-ES-096
- Povidone-iodine 10% w/v in buffered vehicle, cutaneous solution · CGR-ES-097
- Borax 1% w/v mouth-rinse solution · CGR-ES-098
- Racemic menthol 1% w/w in talc · CGR-ES-099
- Boric acid 10% w/w in white soft paraffin · CGR-ES-100
- Salicylic acid 5% w/w ointment with 3% liquid paraffin · CGR-ES-101
- Alibour water with copper sulfate 0.1%, zinc sulfate 0.4% and camphor 0.1% w/v · CGR-ES-102
- Glycerinated alcohol —50 g glycerol plus 50 mL hydroalcoholic vehicle 2 · CGR-ES-103
- Methyl salicylate 1%, menthol 3% and camphor 2.5% w/w analgesic cream · CGR-ES-104
- Boric acid/tannic acid foot powder with thymol · CGR-ES-105
- Barbados aloes dried leaf juice 50 mg — hard capsules · CGR-ES-106
- Cascara bark 300 mg — hard capsules · CGR-ES-107
- Frangula bark 300 mg — hard capsules · CGR-ES-108
- Ispaghula husk with fructose/maltodextrin — powder for oral suspension · CGR-ES-109
- Standardised frangula bark dry extract 50 mg — hard capsules · CGR-ES-110
- Standardised senna leaf dry extract 100 mg — hard capsules · CGR-ES-111
- Fennel fruit 250 mg — hard capsules · CGR-ES-112
- Bearberry leaf 400 mg — herbal powder hard capsules · CGR-ES-113
- Orthosiphon leaf 400 mg — herbal powder hard capsules · CGR-ES-114
- Rosemary leaf 250 mg — herbal powder hard capsules · CGR-ES-115
- Senna leaf 300 mg — hard capsules · CGR-ES-116
- Garlic bulb powder 500 mg — herbal powder hard capsules · CGR-ES-117
- Devil’s claw root 500 mg — herbal powder hard capsules · CGR-ES-118
- Valerian root 500 mg — herbal powder hard capsules · CGR-ES-119
- Psyllium seed powder with fructose/maltodextrin — powder for oral suspension · CGR-ES-120
- Laboratory quality system
- Document control and local adoption · SOP-001
- Request and risk assessment · SOP-002
- Training, hygiene and clothing · SOP-003
- Suppliers, receipt and raw materials · SOP-004
- Facility, cleaning and line clearance · SOP-005
- Equipment, calibration and maintenance · SOP-006
- Calculations and weighing · SOP-007
- Master formulation and batch record · SOP-008
- Oral solutions, syrups and suspensions · SOP-009
- Semisolids, emulsions and gels · SOP-010
- Powders and hard capsules · SOP-011
- Packaging, labelling and handover · SOP-012
- Sampling, QC and release · SOP-013
- Stability and BUD justification · SOP-014
- Deviations, CAPA, complaints and recall · SOP-015
- External testing, data and change control · SOP-016
- Water activity measurement · SOP-017
- Hazardous materials and volatile solvents · SOP-018
- Microbiological quality and preservative effectiveness · SOP-019
- Stability-study applicability and BUD extension · SOP-020
- Storage and transport temperature · SOP-021
- Cleaning verification for actives and allergens · SOP-022
- Clinical excipient and dose review · SOP-023
- Sources versions and scientific publication · SOP-024
- Allergist interface and order verification · OIT-001
- Allergen identity and protein basis · OIT-002
- Allergen segregation and staff protection · OIT-003
- Controlled processing and protein recovery · OIT-004
- Uniformity, redispersibility and dosing device · OIT-005
- Microbiology, packaging and stability · OIT-006
- Allergen label and safe handover · OIT-007
- Incident, recall and reassessment · OIT-008
- Water quality, receipt and use · SOP-025
- Self-audit and quality-system review · SOP-026
- Suitability for an enteral feeding tube · SOP-027
- Water activity, stability evidence and BUD assignment policy · SOP-036
- Forms and worksheets
- Local adoption and risk assessment · F-001
- Master formulation record · F-002
- Blank batch record · F-003
- Equipment and cleaning record · F-004
- Sampling and QC results · F-005
- Stability and BUD rationale · F-006
- Deviation, CAPA and recall · F-007
- Allergen raw-material dossier · F-008
- Allergen process verification · F-009
- Allergen traceability and handover · F-010
- Training and competency · F-011
- Water activity evidence · F-012
- Stability applicability and study plan · F-013
- Temperature and excursions · F-014
- Quantitative cleaning verification · F-015
- Source and publication rights · F-016
- Raw-material receipt and release · F-017
- Supply and traceability · F-018
- Water quality and use record · F-019
- Self-audit and quality review · F-020
- Clinical excipient exposure and device/route suitability · F-021
- Evidence and closure-criteria record · F-022
- Educational technical reviews
- From compounding to formulation design · PUB-001
- Ten potential compounding failure mechanisms · PUB-002
- Compounding documentation with controlled records · PUB-003
- From an unmet need to a development plan · PUB-004
- Ingredient and finished-preparation compatibility · PUB-005
- Stability rationale in pharmacy compounding · PUB-006
- Choosing a dosage form · PUB-007
- Lessons from compounding for product development · PUB-008
- Assessing a case as a research opportunity · PUB-009
- Written procedures for nonsterile compounding · PUB-010
- Compounding records and traceability · PUB-011
- Compounding service in dermatological care · PUB-012
- Practical BUD selection and documentation · PUB-013
- Water activity and interpretation · PUB-014
- Allergen preparations and quality evidence · PUB-015
- Clinical excipient assessment and daily exposure · PUB-016
- Analytical testing and actual delivered dose · PUB-017
- Allergens: development dossiers
- Pistachio — syrup-matrix development dossier · ALG-001
- Peanut — suspension-development dossier · ALG-002
- Cashew and its relationship to pistachio · ALG-003
- Milk allergy and preparation evidence · ALG-004
- Egg allergy and preparation evidence · ALG-005
- Technical appendix
- Amoxicillin 125 mg or 250 mg capsules from 1 g dispersible tablets · TECH-FR-AMOX-001
- Tretinoin 0.025% gel · TECH-ES-TRET-001
- Methodology and use of the Formulary
- The initiative and edition
- A clear message starts the right conversation.
- Privacy and terms of use
- Final decision register
- Collection register
- Sikalias Greek Formulary - Edition 10.0
- Source register
- Topic pathways
- Oral liquids
- Semisolids and topical preparations
- Capsules and powders
- Quality, aw and BUD
- Documentation and traceability
- Allergens: quality framework
- Connect your question with the right team.
- Stasinos Chr. Sikalias
- Connected knowledge. Clear pathways.
- Evidence shows what is known and where it applies.
- About the Sikalias Greek Formulary
- Data, citations and reuse